Imprecise frequency descriptors and the miscomprehension of prescription drug advertising: public policy and regulatory implications

Journal of Technical Writing and Communication

Volumn 29, Issue 2, 1999, Pages 133-152

  Davis, Joel J ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750648469     PISSN: 00472816     EISSN: None     Source Type: Trade Journal    
DOI: 10.2190/R3F8-4HMD-THYE-7JCY     Document Type: Article

References (9)

1. P. G. Pierpaoli, ASHP's Position on Direct-to-Consumer Advertising of Prescription Drugs, American Journal of Hospital Pharmacy, 43, pp. 1763-1766,1986.
2. J. Hodnett, Targetting Consumers, Medical Marketing and Media, 30, p. 91-95,1995.
3. Pharmaceutical Business News, US Drug Companies Target Consumers and Physicians, p. 1, October 10,1995.
4. E. P. Cohen, Are Pharmaceutical Ads Good Medicine? Business and Society Review, 2: pp. 8-10, Spring, 1990.
5. M. J. Sheffet and B. B. Reece, Direct to Consumer Advertising of Prescription Drugs: Issues and Concerns, in Marketing and Public Policy Conference Proceedings, 4, D. J. Ringold (ed.), pp. 5-9,1994.
6. R. Quirk and S. Greenbaum, A University Grammar of English, Longman Publishing, London, England, 1973.
7. J. Toogood, What Do We Mean by 'Usually,' Lancet, I, pp. 1094-1102,1980.
8. H. P. Maat and R. Klaasen, Side Effects of Side Effect Information in Drug Information Leaflets, Journal of Technical Writing and Communication, 24:4, pp. 389-404,1984.
9. Code of Federal Regulations, Prescription Drug Advertising, 21 CFR Part 202: 57-65, 1997.